Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2012
11/08/2012US20120282268 Novel Cell Wall Components of Enterococci and Uses Thereof
11/08/2012US20120282266 Anti-neoplastic uses of artemin antagonists
11/08/2012US20120282265 Medicament and a method for regulation of the vascular tone
11/08/2012US20120282264 Neutralizing antibodies to hiv-1 and their use
11/08/2012US20120282263 Compositions for inhibiting masp-2 dependent complement activation
11/08/2012US20120282259 Mutant smoothened and methods of using the same
11/08/2012US20120282258 Crlf2 in precursor b-cell acute lymphoblastic leukemia
11/08/2012US20120282257 Single-chain variable fragment (scfv) able to recognize and bind cd99 human protein
11/08/2012US20120282256 Chimeric receptors with 4-1bb stimulatory signaling domain
11/08/2012US20120282254 Cd127 binding proteins
11/08/2012US20120282253 Interleukin-10 antibodies
11/08/2012US20120282251 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
11/08/2012US20120282246 Compositions and methods for antibody and ligand identification
11/08/2012US20120282184 Treatment of obesity
11/08/2012US20120282183 Prognostic,. screening and treatment methods and agents for treatment of metastasis and inflammation using 5t4 oncofoetal glycoprotein
11/08/2012US20120282177 ROR1 as Therapeutic and Diagnostic Target
11/08/2012US20120282174 Synergistic Anti-CD47 Therapy for Hematologic Cancers
11/08/2012US20120282173 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient
11/08/2012US20120282170 Anti- tnf antibodies, compositions, methods and uses
11/08/2012CA2834867A1 Formulation for anti-.alpha.4.beta.7 antibody
11/08/2012CA2834456A1 Amino acid sequence presenting fusion polypeptide and its use
11/08/2012CA2832871A1 Compositions for inhibiting masp-2 dependent complement activation
11/08/2012CA2831162A1 An antibody specifically binding to insulin-like growth factor-1
11/07/2012EP2520648A1 Anti-iga1 antibody
11/07/2012EP2520590A2 Cross-species-specific binding domain
11/07/2012EP2520589A1 Anti-cd27 antibody
11/07/2012EP2520588A1 Dual variable domain immunoglobulin and uses thereof
11/07/2012EP2520582A1 Puumala virus full-length M segment-based DNA vaccines
11/07/2012EP2520311A2 Method of treating hemolytic disease
11/07/2012EP2519644A1 Methods for diagnosing the malignant potential of pancreatic cystic lesions
11/07/2012EP2519544A1 Polypeptide heterodimers and uses thereof
11/07/2012EP2519543A1 Heterodimer binding proteins and uses thereof
11/07/2012EP2519542A1 Anti-cdh3 antibodies and uses thereof
11/07/2012EP2519541A1 Ron binding constructs and methods of use thereof
11/07/2012EP2519540A1 Process for the industrial - scale purification of gamma globulins from human plasma for industrial applications
11/07/2012EP2519537A2 Purification of proteins
11/07/2012EP2519536A2 Protein purification by ion exchange
11/07/2012EP2519260A2 Novel modulators of trail signalling
11/07/2012CN1961004B Monoclonal antibody SC104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent
11/07/2012CN1911960B Chlamydia protein, gene sequence and uses thereof
11/07/2012CN1524088B A virus causing respiratory tract illness in susceptible mammals
11/07/2012CN102770537A Polypeptide modification method for purifying polypeptide multimers
11/07/2012CN102770457A Antigen presenting cell targeted vaccines
11/07/2012CN102770456A Multispecific antibodies, antibody analogs, compositions, and methods
11/07/2012CN102770455A Method for in vivo expansion of T regulatory cells
11/07/2012CN102770454A Activatable constructs
11/07/2012CN102770453A Anti-FLT3 antibodies and methods of using the same
11/07/2012CN102770452A An IgY for a PA-MSHA bacterial strain, and preparation method and application thereof
11/07/2012CN102770451A Dual variable domain immunoglobulins and uses thereof
11/07/2012CN102770158A Antibody formulation
11/07/2012CN102768276A Indirect ELISA (enzyme linked immunosorbent assay) kit for alicyclobacillus and application thereof
11/07/2012CN102766640A Method for preparing influenza A virus full-length M2 protein
11/07/2012CN102766213A Monoclonal antibody, enzyme-linked immunosorbent assay method and kit for detecting furaltadone residue marker AMOZ
11/07/2012CN102766212A Monoclonal antibody, enzyme-linked immunosorbent assay method and kit for detecting residues of fluoroquinolones
11/07/2012CN102766211A Monoclonal antibody, enzyme-linked immunosorbent assay method and kit for detecting arsanilic acid, nitarsone and Carbarsone
11/07/2012CN102766210A Human CTLA-4 antibodies and their uses
11/07/2012CN102766209A Monoclonal antibody of anti-perkinsus membrane protein, preparation method and application thereof
11/07/2012CN102766208A Monoclonal antibody, enzyme-linked immunosorbent assay method and kit for detecting T-2 and HT-2 toxin
11/07/2012CN102766207A Bactrian camel heavy-chain (HC) variable-domain antibody resisting porcine circovirus 2 as well as preparation method and application thereof
11/07/2012CN102766202A PHF14 C-terminal protein, its polyclonal antibody and application thereof
11/07/2012CN102766195A Monoclonal antibody recongnizing epitope for HCV (hepatitis C virus) NS3 helicase ATP (adenosine triphosphate) binding site
11/07/2012CN102764436A Treatment of TNF alpha related disorders
11/07/2012CN101987836B Chlorpromazine hapten, artificial antigen, antibody as well as preparation method and application thereof
11/07/2012CN101948535B Method for separating immunoglobulin IgY from chicken blood
11/07/2012CN101891817B Monoclonal antibody capable of preventing high mobility group box-1 (HMGB-1) and application thereof
11/07/2012CN101891814B Anti-osteopontin OPN monoclonal antibody and application thereof
11/07/2012CN101863975B HBV (Hepatitis B Virus) preS1 B cell epitope peptide, hybridoma cell strain prepared by same and application
11/07/2012CN101830983B Preparation and application of specific sequence-based aquaporin 4 high titer antibody
11/07/2012CN101678101B Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of B-chronic lymphocytic leukemia
11/07/2012CN101671654B Monoclonal antibody resisting anaplasma marginale MSP5 protein and application thereof
11/07/2012CN101553503B SHRNA-mediated inhibition of expression of alpha-1,6-fucosyltransferase
11/06/2012US8304382 Anti-inflammatory and anti-allergic cyclic peptides
11/06/2012US8304258 Methods of producing monoclonal antibodies specific for human hepcidin
11/06/2012US8304200 Methods for obtaining antibodies
11/06/2012US8304197 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
11/06/2012US8303960 Radiolabeled affibody molecules
11/06/2012US8303958 Method of treating immunological disorders by administering truncated BAFF receptors
11/06/2012US8303956 Glycosylated specificity exchangers
11/06/2012US8303955 Humanized anti-CD40 antibodies and their methods of use
11/06/2012US8303954 Anti-Aβ oligomer humanized antibody
11/06/2012US8303951 Neutrokine-alpha antibodies and methods of use thereof
11/06/2012US8303922 Method for exfoliation of hexagonal boron nitride
11/06/2012CA2545359C Compositions and methods for regulation of tumor necrosis factor-alpha
11/06/2012CA2450939C Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
11/06/2012CA2434737C Non aggregating fluorescent proteins and methods for using the same
11/06/2012CA2393467C Chordin-like molecules and uses thereof
11/06/2012CA2365533C Diagnosis and treatment of neuroectodermal tumors
11/06/2012CA2305630C Soluble single-chain t-cell receptor proteins
11/01/2012WO2012149562A2 Selective anti-hla antibody removal device and methods of production and use thereof
11/01/2012WO2012149536A1 Neutralizing antibodies to nipah and hendra virus
11/01/2012WO2012149365A2 Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies
11/01/2012WO2012149356A2 Anti-cd40 antibodies and methods of use
11/01/2012WO2012149320A1 Ip-10 antibody dosage escalation regimens
11/01/2012WO2012149299A2 Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
11/01/2012WO2012149047A1 Multimer glycosylated nucleic acid binding protein conjugates and uses thereof
11/01/2012WO2012148003A1 ANTI-HUMAN RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE σ ANTIBODY
11/01/2012WO2012147992A1 ANTI-iPS/ES CELL-SPECIFIC ANTIBODY AND USE THEREOF
11/01/2012WO2012147918A1 Monoclonal antibody for human telomerase reverse transcriptase
11/01/2012WO2012147713A1 Anti-b7-h3 antibody
11/01/2012WO2012147053A1 A method for reducing heterogeneity of antibodies and a process of producing the antibodies thereof
1 ... 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 ... 1494